Science Explorer Back to mapMap
Institution · Izumi Biosciences

Most cited papers from Izumi Biosciences

What are the most cited papers from Izumi Biosciences?

The most cited paper from Izumi Biosciences is "Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain" (Christopher A. Fasano, Timothy N. Phoenix, Erzsebet Kokovay et al., 2009), with 166 citations. Next come "Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V" (52) and "Regenerative Medicine and Stem Cell Based Drug Discovery" (39).

Showing 10 of 10 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain Christopher A. Fasano, Timothy N. Phoenix, Erzsebet Kokovay et al. · Genes & Development Open access Mar 2009 166
2 Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V Tahereh Tavakoli, X.Z. Shawn Xu, Eric G. Derby et al. · BMC Cell Biology Open access 5 Jun 2009 52
3 Regenerative Medicine and Stem Cell Based Drug Discovery Kazuhiro Sakurada, Fiona M. McDonald, Fumiki Shimada · Angewandte Chemie International Edition 15 Jul 2008 39
4 Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients Erwin Alexander van Vliet, Anand M. Iyer, Lucia Mesarosova et al. · Journal of Neuropathology & Experimental Neurology Open access 27 Dec 2019 37
5 Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease Tamàs Fülöp, Shreyansh Tripathi, Serafim Rodrigues et al. · Neuropsychiatric Disease and Treatment Open access May 2021 29
6 In Vitro Assessment of the Neuroprotective Effects of Pomegranate (Punica granatum L.) Polyphenols Against Tau Phosphorylation, Neuroinflammation, and Oxidative Stress Mehdi Alami, Kaoutar Boumezough, Echarki Zerif et al. · Nutrients Open access 28 Oct 2024 21
7 Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ 1–42 -induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease Mehdi Alami, Echarki Zerif, Abdelouahed Khalil et al. · Journal of Alzheimer s Disease 20 Mar 2025 12
8 BCRP expression in schwannoma, plexiform neurofibroma and MPNST Maurits de Vries, Olaf van Tellingen, Andel G. L. van der Mey et al. · Oncotarget Open access 16 Sep 2017 5
9 Pomegranate (Punica granatum L.) Bioactive Compounds Alleviate Human Beta-Amyloid-(1-42)-Induced Tau-phosphorylation, Neuronal Death, Oxidative Stress and Reduced LPS-Induced Neuroinflammation in Alzheimer’s Disease Mehdi Alami, Kaoutar Boumezough, Ecahrki Zerif et al. · Preprints.org PreprintOpen access 30 Jul 2024 3
10 Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer’s potential against amyloid-beta1–42-induced neurodegeneration Mehdi Alami, Hicham Berrougui, Kaoutar Boumezough et al. · Mechanisms of Ageing and Development 16 Feb 2026 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.